Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Clasificación en acciones #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Precio por acción
$0.00185055
Capitalización bursátil
$48.29K
Cambio (1 día)
-3.55%
Cambio (1 año)
30.31%
País
GB
Comercio Nuformix plc (NFX)

Categoría

Historial de desdoblamientos de acciones de Nuformix plc (NFX)
La acción Nuformix plc (símbolo: NFX) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Sep 23, 2026.
Una acción NFX comprada antes de Sep 23, 2026 equivaldría hoy a 0 acciones NFX.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH